IOL Chemicals Submits Integrated Annual Report for FY 2025-26

IOL Chemicals & Pharmaceuticals Ltd has submitted its Integrated Annual Report for the financial year 2025-26. The report includes the Notice for the 39th Annual General Meeting (AGM), scheduled for September 2, 2026, at 11:30 a.m. IST, to be conducted via Video Conferencing. The report is available electronically to members and on the company's website. It highlights the company's 'Guiding Compass Journey Forward' strategy, emphasizing consistent quality, diversification, disciplined execution, innovation, and sustainability. The report covers a legacy of forty years, mentioning 14 USFDA Drug Master Files and 21 EDQM Certificates of Suitability, and positions the company to advance API manufacturing in India's growing pharmaceutical sector.